Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock 
Instagram Outage Disrupts Thousands of U.S. Users 
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
Gettysburg, PA, Oct. 18, 2017 -- Genoa, a QoL Healthcare company, the nation’s leading behavioral health pharmacy and telepsychiatry company, announced today that it will host a live, complimentary executive web briefing titled, “100,000 Visits Later: Lessons on Building a Sustainable Telepsychiatry Program,” on Thursday, Nov. 2 at 2:00 p.m. ET. The web briefing will offer expert, best-practice advice from Samir Malik, general manager of Genoa Telepsychiatry.
“With more than 50 state-run Medicaid programs in the U.S., understanding the reimbursement environment for telepsychiatry is required to build a good program,” said Malik. “In addition to navigating the various reimbursement rates set by each state, one also has to understand regulatory requirements around what types of care can be delivered, in what settings, by whom, and under what conditions. All of these factors can seem intimidating, but need not be with the right understanding.”
Moderated by OPEN MINDS, the webinar will provide information on the favorability of the telepsychiatry market in all 50 states, as ranked by gross reimbursement potential; flexibility in location of service delivered; an unmet need for adults; an unmet need for children; and any restrictions on licensing.
The informative executive web briefing will specifically cover:
- The current reimbursement environment for telepsychiatry; and
- How to build a financially sustainable telepsychiatry program.
To learn more about this executive web briefing, or take advantage of free online registration, please visit: https://www.openminds.com/event/100000-visits-later-lessons-building-sustainable-telepsychiatry-programs/. All registrants will receive (at no charge and regardless of attendance) a recording of the webinar and an electronic copy of the presentation slides at its conclusion.
* * *
ABOUT Genoa Telepsychiatry
Genoa, a QoL Healthcare Company is the leading pharmacy and telepsychiatry provider serving the behavioral health and addiction treatment communities for over 15 years. Our pharmacy and telepsychiatry services impact more than 550,000 individuals annually in 45 states and the District of Columbia. Our network of 380 pharmacies fills over 13 million prescriptions annually. For more information visit https://genoatelepsychiatry.com.
ABOUT OPEN MINDS
OPEN MINDS is a national health and human service industry market intelligence firm. Founded in 1987 and based in Gettysburg, Pennsylvania, the 75+ associates provide innovative management solutions designed to improve operational and strategic performance. Learn more at www.openminds.com.
OPEN MINDS Executive Education Events Team OPEN MINDS 7173341329 [email protected]
